STOCK TITAN
  1. Home
  2. Sec-filings
  3. IGC
  4. [EFFECT] IGC Pharma, Inc. SEC Filing

[EFFECT] IGC Pharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 5, 2025 4:00 P.M.
Form: S-3
CIK: 0001326205
Company Name: IGC Pharma, Inc.
File Number: 333-291567

Source: View Original Filing on SEC EDGAR

Stock IGC logo
IGC Pharma Inc

NYSE:IGC

IGC Rankings

#5937 Ranked by Market Cap
N/A Ranked by Dividends

IGC Latest News

Feb 2, 2026
IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation
Jan 22, 2026
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial Site at Integrative Clinical Trials in New York
Jan 12, 2026
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship Network Site, in Richmond, Virginia
Jan 6, 2026
IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability
Jan 5, 2026
IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial

IGC Latest SEC Filings

Jan 20, 2026
[Form 4] IGC Pharma, Inc. Insider Trading Activity
Jan 5, 2026
[8-K] IGC Pharma, Inc. Reports Material Event
Jan 5, 2026
[424B5] IGC Pharma, Inc. Prospectus Supplement (Debt Securities)
Jan 2, 2026
[8-K] IGC Pharma, Inc. Reports Material Event
Dec 15, 2025
[8-K] IGC Pharma, Inc. Reports Material Event

IGC Stock Data

26.05M
88.18M
8.45%
18.55%
1%
Biotechnology
Pharmaceutical Preparations
Link
United States
POTOMAC